


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-19.19%
-25.72%
+9.03%
-5.38%
-4.47%
SNDX
Syndax Pharmaceutica
$20.15
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
SNDX Price Performance
$21 (-4.05%)
$17.73 (+13.65%)
$15.84 (+27.21%)
$15.67 (+28.59%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SNDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNDX Street Sentiment is extremely bullish and have negative views on the near-term outlook
SNDX has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Nov 28, 2025
Price Target Raised
Overweight
Barclays
Nov 25, 2025
Reiterate
Overweight
Barclays
Nov 13, 2025
Reiterate
Overweight
JP Morgan
Nov 05, 2025
Reiterate
Buy
UBS
Nov 05, 2025
Reiterate
Overweight
Barclays
What is SNDX current stock price?
What are SNDX stock strengths?
What is SNDX Risk Level?
What is SNDX market cap and volume?
What is SNDX current Stock IQ?
Should I buy SNDX stock right now?
Is SNDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for SNDX?
What does a 'Strong Sell' rating mean for SNDX?
What factors influence SNDX's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-19.19%
-25.72%
+9.03%
-5.38%
-4.47%
SNDX
Syndax Pharmaceutica
Current Price
$20.15

SNDX Price Performance
$21 (-4.05%)
$17.73 (+13.65%)
$15.84 (+27.21%)
$15.67 (+28.59%)
SNDX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
SNDX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SNDX Street Sentiment is extremely bullish and have negative views on the near-term outlook
SNDX has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Nov 28, 2025
Price Target Raised
Overweight
Barclays
Nov 25, 2025
Reiterate
Overweight
Barclays
Nov 13, 2025
Reiterate
Overweight
JP Morgan
Nov 05, 2025
Reiterate
Buy
UBS
Nov 05, 2025
Reiterate
Overweight
Barclays
SNDX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
SNDX Latest Analysis
Syndax Announces Participation at the 2026 Guggenheim Emerging Outlook: Biotech Summit. ) a commercial-stage biopharmaceutical company advancing innovative cancer therapies today announced that Michael A. Metzger Chief Executive Officer will participate in a fireside chat at the 2026 Guggenheim Emerging Outlook: Biotech Summit on Thursday February 12 2026 at 12:30 p.m. ET.
Today
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SNDX Stock trends
SNDX Stock performance
SNDX Stock analysis
SNDX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.